LeMaitre Vascular reports 11% Q1 sales growth, raises full-year guidance with 26% EPS growth forecast.

LeMaitre Vascular posted Q1 2026 sales of $66.6 million, up 11% year-over-year, driven by strong product sales and geographic expansion. Gross margin improved to 72.7%, and operating income rose 41% to $17.8 million, resulting in a 42% increase in earnings per share to $0.68. The company declared a quarterly dividend of $0.25 per share and announced a $100 million share repurchase program. For 2026, LeMaitre expects 12% sales growth and 26% adjusted EPS growth, reflecting continued operational leverage and market expansion.